Hello, Fool! | Login | Signup | My Fool
Oct 12, 2008 12:45 AM ET | Feedback | Site Changes | Help
A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.
View All Commentary (CELG)
Recs
Whoop04 (77.49) Submitted: 10/13/06 9:34 PM : Start Price: $45.90 CELG Score: 53.95
10/200694Earnings Per Share (EPS) Rating 97Relative Price Strength (RS) Rating 88Industry Group Relative Strength (Grp RS) Rating A-Sales + Profit Margins + ROE (SMR) Rating AAccumulation/ Distribution (Acc/Dis) RatingB-
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK